PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors

This publication has 57 references indexed in Scilit:

• Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries
  Annals of Oncology, 2011
• DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
  Science, 2011
• PTEN Loss Accelerates Kras G12D-Induced Pancreatic Cancer Development
  Cancer Research, 2010
• New drugs in neuroendocrine tumors: rising of new therapeutic philosophies?
  Current Opinion in Oncology, 2010
• Targeting the phosphoinositide 3-kinase pathway in cancer
  Nature Reviews Drug Discovery, 2009
• Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
  Gastroenterology, 2008
• Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
  Cancer, 2008
• mTOR and cancer: insights into a complex relationship
  Nature Reviews Cancer, 2006
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
  Nature Reviews Genetics, 2006
• A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
  Cell, 2006